Pharmacokinetics of quinolones;Pharmakokinetik der chinolone

Chemotherapie Journal, Supplement

Volumn 11, Issue 20, 2001, Pages 25-33

  Sörgel, Fritz ^a   Bulitta, Jürgen ^a   Kinzig Schippers, Martina ^a  

^a Inst Biomed Pharmazeut Forschung   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFLOXACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; CLINDAMYCIN; DIFLOXACIN; ENOXACIN; FLEROXACIN; GEMIFLOXACIN; GLYCOPEPTIDE; LEVOFLOXACIN; LOMEFLOXACIN; MACROLIDE; METRONIDAZOLE; MOXIFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; PIPEMIDIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RUFLOXACIN; SPARFLOXACIN; TEMAFLOXACIN; TETRACYCLINE; TROVAFLOXACIN;

ANTIBIOTIC RESISTANCE; AREA UNDER THE CURVE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ELIMINATION; DRUG METABOLISM; HUMAN; KIDNEY EXAMINATION; NONHUMAN; PHARMACODYNAMICS; PKA; STREPTOCOCCUS PNEUMONIAE;

EID: 0035757799     PISSN: 09446486     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Limitations in the use of drug cocktails (DC) to compare the pharmacokinetics of drugs: Ciprofloxacin (CIP) vs. levofloxacin (LEV)
2. Lack of interaction between levofloxacin and oxycodone: Pharmacokinetics and drug disposition
3. Absence of drug interaction between oral Moxifloxacin and intramuscular morphine sulfate in healthy volunteers
4. Clinical pharmacokinetics in patients with burns
5. Pharmacokinetic interactions related to the chemical structures of Fluoroquinolones
6. Pharmacokinetics of orally administered Ciprofloxacin in abdominal surgery
7. Lipophilicity at pH 7.4 and molecular size govern the entry of the free serum fractions of drugs into the cerebrospinal fluid in humans with uninflamed Meninges
8. Influence of rifampin on fleroxacin pharmacokinetics
9. Pharmacokinetic disposition of quinolones in human body fluids and tissues
10. Pharmacokinetics of gyrase inhibitors. Part 1: Basic chemistry and gastrointestinal disposition
11. Pharmacokinetics of gyrase inhibitors. Part 2: Renal and hepatic elimination pathways and drug interactions
12. Brief report: Gastrointestinal secretion of ciprofloxacin
13. Gender related distribution of quinolones
14. Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: A Review
15. Aktuelle pharmakokinetische aspekte der gyrasehemmer - Beziehung der kinetik zu struktur und physikalisch-chemischen eigenschaften
16. Pharmakokinetik und pharmakodynamik von levofloxacin
17. High dose treatment with antibiotics in cystic fibrosis - A reappraisal with special reference to the pharmacokinetics of betalactams and new fluoroquinolones in adult CF-patients
18. Metabolism of gyrase inhibitors
19. Absorption differences of Ciprofloxacin along the human gastrointestinal tract determined using a remote control drug delivery device (HF-Capsule)
20. Pharmacokinetics of levofloxacin in comparison to the racemic mixture of ofloxacin in man
21. Plasma protein binding of gyrase inhibitors
22. Pharmakokinetik der chinolone